T. Rowe Price Associates
CDXS icon

T. Rowe Price Associates’s Codexis CDXS Stock Holding History

T. Rowe Price Associates’s Portfolio CDXS Stock Details CDXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$152K Buy
66,924
+3,331
+5% +$8.29K ﹤0.01% 3074
2026
Q1 		$104K Buy
63,593
+19,324
+44% +$27.5K ﹤0.01% 2992
2025
Q4 		$73K Hold
44,269
– – ﹤0.01% 2988
2025
Q3 		$109K Buy
44,269
+3,772
+9% +$10.3K ﹤0.01% 2907
2025
Q2 		$99K Buy
40,497
+6,298
+18% +$14.8K ﹤0.01% 2893
2025
Q1 		$92K Buy
34,199
+2,647
+8% +$10.3K ﹤0.01% 2837
2024
Q4 		$151K Buy
31,552
+8,832
+39% +$36.4K ﹤0.01% 2765
2024
Q3 		$70K Buy
22,720
+1,926
+9% +$5.96K ﹤0.01% 2883
2024
Q2 		$65K Hold
20,794
– – ﹤0.01% 2821
2024
Q1 		$73K Buy
20,794
+2,314
+13% +$7.29K ﹤0.01% 2828
2023
Q4 		$57K Sell
18,480
-29,376
-61% -$63.1K ﹤0.01% 2787
2023
Q3 		$91K Buy
47,856
+2,203
+5% +$5.15K ﹤0.01% 2687
2023
Q2 		$128K Buy
45,653
+1,395
+3% +$4.51K ﹤0.01% 2642
2023
Q1 		$184K Buy
44,258
+368
+0.8% +$1.93K ﹤0.01% 2551
2022
Q4 		$205K Buy
43,890
+1,176
+3% +$6.45K ﹤0.01% 2523
2022
Q3 		$259K Buy
42,714
+23,351
+121% +$188K ﹤0.01% 2441
2022
Q2 		$203K Buy
19,363
+419
+2% +$5.25K ﹤0.01% 2596
2022
Q1 		$391K Buy
18,944
+1,373
+8% +$28.4K ﹤0.01% 2450
2021
Q4 		$549K Buy
+17,571
New +$578K ﹤0.01% 2344
2021
Q2 		– Sell
-791,032
Closed -$18.1M – 2924
2021
Q1 		$18.1M Buy
791,032
+82,298
+12% +$1.93M ﹤0.01% 1296
2020
Q4 		$15.5M Buy
+708,734
New +$11.7M ﹤0.01% 1280
2013
Q4 		– Sell
-11,859
Closed -$21K – 2489
2013
Q3 		$21K Hold
11,859
– – ﹤0.01% 2455
2013
Q2 		$26K Buy
+11,859
New +$26.8K ﹤0.01% 2422

Other funds holding CDXS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates's CDXS Position: Q2 2026 in Review

T. Rowe Price Associates increased its Codexis (CDXS) stake by 5.2% in Q2 2026, buying an estimated $8.29K and bringing the position to 66,924 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #3074.

T. Rowe Price Associates first reported a position in CDXS in Q2 2013 and has held it in 23 quarters since. The position peaked at $18.1M in Q1 2021. 149 funds tracked by Wall St. Rank hold CDXS as of Q2 2026.

  • T. Rowe Price Associates held 66,924 shares of Codexis worth $152K as of Q2 2026.
  • T. Rowe Price Associates bought 3,331 Codexis shares in Q2 2026, an estimated $8.29K.
  • Codexis made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #3074 holding.
  • T. Rowe Price Associates first reported a position in Codexis in Q2 2013 and has held it in 23 quarters since.
  • T. Rowe Price Associates's Codexis position peaked at $18.1M in Q1 2021.
  • 149 funds tracked by Wall St. Rank held Codexis as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.